Penn Med Team Reports on Study of First 59 Leukemia Patients Who Received Personalized Cellular Therapy
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies.
University of Pennsylvania researchers have found a way of traversing the blood-brain barrier, as well as a similar physiological obstacle in the eye, the retinal-blood barrier, to significantly degrade brain plaques associated with Alzheimer's disease.
There is an optimal amount of strain that a beating heart can generate and still beat at its usual rate, once per second. Researchers at the University of Pennsylvania have now shown that this “sweet spot” depends on the stiffness of the collagen framework that the heart’s cells live within.
A new brain connectivity study from Penn Medicine published today in the Proceedings of National Academy of Sciences found striking differences in the neural wiring of men and women that’s lending credence to some commonly-held beliefs about their behavior.
Penn in the news
Neil Fishman of the Perelman School of Medicine comments on there not being enough science to support the wide use of yogurt or probiotics.
Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School discusses how to measure success for the Affordable Care Act legislation.
Ragini Verma of the Perelman School of Medicine is cited for studying brain differences between men and women.
Researchers from the Perelman School of Medicine are cited for collaborating with the Children’s Hospital of Philadelphia for studying T-cell effectiveness on leukemia.
The Botswana-UPenn Partnership is highlighted.